Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells

K. Satyamoorthy, M. P. Chitnis, S. G. Pradhan, S. H. Advani

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    Calcium channel-blocking agent verapamil has been established to bean effective drug to modulate the action of many anticancer drugs. In this study, we examined the effect of verapamil on the cytotoxicity of mitoxantrone in human chronic myeloid leukemia (CML) cells. Mitoxantrone alone exhibited dose-dependent inhibition of DNA biosynthesis in CML cells. The addition of verapamil (3.3 μM) enhanced the responsiveness of CML cells to mitoxantrone (I μg/ml) cytotoxicity indicated by significant increased inhibition of thymidine incorporation (p < 0.001). The present study demonstrates the possible efficacy of verapamil in the chemotherapy of CML with mitoxantrone.

    Original languageEnglish
    Pages (from-to)128-131
    Number of pages4
    JournalOncology (Switzerland)
    Volume46
    Issue number2
    DOIs
    Publication statusPublished - 1989

    Fingerprint

    Mitoxantrone
    Myeloid Cells
    Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    Verapamil
    Calcium Channels
    Pharmaceutical Preparations
    Thymidine
    Drug Therapy
    DNA

    All Science Journal Classification (ASJC) codes

    • Oncology
    • Cancer Research

    Cite this

    Satyamoorthy, K. ; Chitnis, M. P. ; Pradhan, S. G. ; Advani, S. H. / Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells. In: Oncology (Switzerland). 1989 ; Vol. 46, No. 2. pp. 128-131.
    @article{ca08de524e434bb8be0369587044c91c,
    title = "Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells",
    abstract = "Calcium channel-blocking agent verapamil has been established to bean effective drug to modulate the action of many anticancer drugs. In this study, we examined the effect of verapamil on the cytotoxicity of mitoxantrone in human chronic myeloid leukemia (CML) cells. Mitoxantrone alone exhibited dose-dependent inhibition of DNA biosynthesis in CML cells. The addition of verapamil (3.3 μM) enhanced the responsiveness of CML cells to mitoxantrone (I μg/ml) cytotoxicity indicated by significant increased inhibition of thymidine incorporation (p < 0.001). The present study demonstrates the possible efficacy of verapamil in the chemotherapy of CML with mitoxantrone.",
    author = "K. Satyamoorthy and Chitnis, {M. P.} and Pradhan, {S. G.} and Advani, {S. H.}",
    year = "1989",
    doi = "10.1159/000226699",
    language = "English",
    volume = "46",
    pages = "128--131",
    journal = "Oncology",
    issn = "0030-2414",
    publisher = "S. Karger AG",
    number = "2",

    }

    Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells. / Satyamoorthy, K.; Chitnis, M. P.; Pradhan, S. G.; Advani, S. H.

    In: Oncology (Switzerland), Vol. 46, No. 2, 1989, p. 128-131.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells

    AU - Satyamoorthy, K.

    AU - Chitnis, M. P.

    AU - Pradhan, S. G.

    AU - Advani, S. H.

    PY - 1989

    Y1 - 1989

    N2 - Calcium channel-blocking agent verapamil has been established to bean effective drug to modulate the action of many anticancer drugs. In this study, we examined the effect of verapamil on the cytotoxicity of mitoxantrone in human chronic myeloid leukemia (CML) cells. Mitoxantrone alone exhibited dose-dependent inhibition of DNA biosynthesis in CML cells. The addition of verapamil (3.3 μM) enhanced the responsiveness of CML cells to mitoxantrone (I μg/ml) cytotoxicity indicated by significant increased inhibition of thymidine incorporation (p < 0.001). The present study demonstrates the possible efficacy of verapamil in the chemotherapy of CML with mitoxantrone.

    AB - Calcium channel-blocking agent verapamil has been established to bean effective drug to modulate the action of many anticancer drugs. In this study, we examined the effect of verapamil on the cytotoxicity of mitoxantrone in human chronic myeloid leukemia (CML) cells. Mitoxantrone alone exhibited dose-dependent inhibition of DNA biosynthesis in CML cells. The addition of verapamil (3.3 μM) enhanced the responsiveness of CML cells to mitoxantrone (I μg/ml) cytotoxicity indicated by significant increased inhibition of thymidine incorporation (p < 0.001). The present study demonstrates the possible efficacy of verapamil in the chemotherapy of CML with mitoxantrone.

    UR - http://www.scopus.com/inward/record.url?scp=0024545740&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0024545740&partnerID=8YFLogxK

    U2 - 10.1159/000226699

    DO - 10.1159/000226699

    M3 - Article

    VL - 46

    SP - 128

    EP - 131

    JO - Oncology

    JF - Oncology

    SN - 0030-2414

    IS - 2

    ER -